Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.

Saved in:
Bibliographic Details
Title: Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.
Authors: Chan, Conrad1 (AUTHOR), Prozzo, Vanessa1 (AUTHOR), Aghevlian, Sadaf1 (AUTHOR), Reilly, Raymond M.1,2,3,4 (AUTHOR) raymond.reilly@utoronto.ca
Source: EJNMMI Radiopharmacy & Chemistry. 12/21/2022, Vol. 7 Issue 1, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 160907790
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [<superscript>111</superscript>In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Chan%2C+Conrad%22">Chan, Conrad</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prozzo%2C+Vanessa%22">Prozzo, Vanessa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aghevlian%2C+Sadaf%22">Aghevlian, Sadaf</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reilly%2C+Raymond+M%2E%22">Reilly, Raymond M.</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<i> raymond.reilly@utoronto.ca</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22EJNMMI+Radiopharmacy+%26+Chemistry%22">EJNMMI Radiopharmacy & Chemistry</searchLink>. 12/21/2022, Vol. 7 Issue 1, p1-21. 21p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160907790
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s41181-022-00186-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 21
        StartPage: 1
    Titles:
      – TitleFull: Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan, Conrad
      – PersonEntity:
          Name:
            NameFull: Prozzo, Vanessa
      – PersonEntity:
          Name:
            NameFull: Aghevlian, Sadaf
      – PersonEntity:
          Name:
            NameFull: Reilly, Raymond M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 12
              Text: 12/21/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2365421X
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: EJNMMI Radiopharmacy & Chemistry
              Type: main
ResultId 1